Issuer Free Writing Prospectus

Issuer Free Writing Prospectus filed pursuant to Rule 433

supplementing the preliminary prospectus dated June 1, 2009

and the prospectus dated June 1, 2009

Registration No. 333-159640

June 3, 2009

BARCLAYS CAPITAL

Equity Syndicate

Pricing Term Sheet

Iconix Brand Group, Inc.

10,000,000 Shares of Common Stock

June 3, 2009

Pricing Supplement

Pricing Supplement dated June 3, 2009 to preliminary prospectus dated June 1, 2009 of Iconix Brand Group, Inc. This Pricing Supplement is qualified in its entirety by reference to the preliminary prospectus. The information in this Pricing Supplement supplements the preliminary prospectus and supersedes the information in the preliminary prospectus to the extent it is inconsistent with the information in the preliminary prospectus. Capitalized terms used in this Pricing Supplement but not defined have the meanings given them in the preliminary prospectus.

 

Issuer:    Iconix Brand Group, Inc., a Delaware corporation
Offering Size:    10,000,000 shares of Common Stock, consisting of 9,200,000 primary shares of Common Stock and 800,000 secondary shares of Common Stock
Greenshoe:    1,500,000 primary shares of Common Stock
Symbol:    ICON (NASDAQ)
Price to the Public:    $15.00

Last reported sale price

on June 3, 2009:

   $15.84
Gross Spread:    $0.6375
Aggregate Gross Spread:    $6,375,000

Net proceeds to Issuer

after expenses:

   $131,395,900
Trade Date:    June 4, 2009
Settlement Date:    June 9, 2009
CUSIP Number:    451055107


Additional Information:

In addition to the pricing information set forth above, the following sections of the preliminary prospectus will be updated to reflect the following changes:

Consolidated balance sheet data:

 

(in thousands except footnotes)    As of March 31,
2009
     As
Adjusted

Cash(1)

   $ 175,228

Working capital

   $ 165,381

Total assets

   $ 1,530,121

Total current liabilities

   $ 72,085

Long-term debt, less current portion (2)

   $ 531,503

Other liabilities

   $ 132,350

Stockholders’ equity

   $ 794,183

 

(1)    Including restricted cash of $5.1 million at March 31, 2009.

(2)    As adjusted, due to implementation of FSP APB 14-1.

 

2


Capitalization table:

 

(in thousands except par value and footnotes)    As of March 31,
2009
 
     As
Adjusted
 

Cash (including restricted cash of $5,103)

   $ 175,228  
        

Long-term debt, including current maturities:

  

Convertible notes(1)

     236,935  

Term Loan facility

     217,187  

Asset-backed notes

     111,716  

Sweet note

     12,186  
        

Total

   $ 578,024  
        

Stockholders’ equity:

  

Common stock, $.001 par value, authorized 150,000 shares (actual and as adjusted); 58,077 shares issued and outstanding (actual) and 67,789 shares issued and outstanding (as adjusted)

     68  

Additional paid-in capital

     667,267  

Retained earnings

     136,007  

Accumulated other comprehensive loss

     (3,912 )

Treasury stock – 1,125 shares at cost

     (7,167 )
        

Total Iconix Stockholders’ Equity

     792,263  
        

Non-controlling interest

     1,920  
        

Total Stockholders’ equity

     794,183  
        

Total capitalization

   $ 1,530,121  
        

 

(1) Reflects the net debt carrying amount of the convertible notes as adjusted for the adoption of FSP APB 14-1. The principal amount owed to the holders of the convertible notes is $287.5 million.

The issuer has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission (SEC) for this offering to which this communication relates. Before you invest, you should read the prospectus for this offering in that registration statement, and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by searching the SEC online database (EDGAR®) at www.sec.gov. Alternatively, you may obtain a copy of the prospectus from Barclays Capital Inc. by emailing barclaysprospectus@broadridge.com or calling 1 (888) 603-5847.

 

3